Assignee
INTERCEPT PHARMACEUTICALS INC
US·51 granted patents·43 pending applications·260 citations·filing 2002–2025
Top patents by PatentIndex Score
94 records- 0197US9611289B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2014·Granted Apr 4, 2017·13 cites·20 claims
- 0296US10532061B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Jan 14, 2020·5 cites·6 claims
- 0396US9763964B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·23 cites·7 claims
- 0495US7786102B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2006·Granted Aug 31, 2010·20 cites·3 claims
- 0594US9732116B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·20 cites·10 claims
- 0694US8377916B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2011·Granted Feb 19, 2013·15 cites·4 claims
- 0794US7932244B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2007·Granted Apr 26, 2011·24 cites·8 claims
- 0893US10052337B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Aug 21, 2018·21 cites·19 claims
- 0992US7858608B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2009·Granted Dec 28, 2010·21 cites·5 claims
- 1092US7812011B2Steroid agonist for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2005·Granted Oct 12, 2010·18 cites·11 claims
- 1191US7994352B2Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acidINTERCEPT PHARMACEUTICALS INC·Filed 2006·Granted Aug 9, 2011·22 cites·39 claims
- 1290US9238673B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jan 19, 2016·12 cites·23 claims
- 1388US2024398834A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1487US11345721B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted May 31, 2022·2 cites·6 claims
- 1587US10800807B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Oct 13, 2020·3 cites·17 claims
- 1687US10758549B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted Sep 1, 2020·2 cites·33 claims
- 1787US9732117B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·3 cites·10 claims
- 1887US2026000682A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1986US2023233581A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2085US10894054B2FXR agonist compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Jan 19, 2021·3 cites·8 claims
- 2184US9777038B2Process for preparing bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Oct 3, 2017·3 cites·6 claims
- 2284US9650409B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted May 16, 2017·4 cites·8 claims
- 2384US9243027B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jan 26, 2016·5 cites·17 claims
- 2484US2025011360A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2583US11034717B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Jun 15, 2021·3 cites·10 claims
- 2683US10646499B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted May 12, 2020·1 cites·20 claims
- 2783US2023340010A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2882US10815267B23-desoxy derivative and pharmaceutical compositions thereofINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Oct 27, 2020·1 cites·4 claims
- 2982US9540414B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·4 cites·2 claims
- 3081US11000532B2Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2019·Granted May 11, 2021·0 cites·16 claims
- 3181US10421772B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·1 cites·8 claims
- 3281US10047117B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·2 cites·13 claims
- 3381US9090652B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jul 28, 2015·3 cites·9 claims
- 3481US8969330B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Mar 3, 2015·2 cites·7 claims
- 3580US11066437B2Methods and intermediates for the preparation of bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·2 cites·22 claims
- 3679US2025376488A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3778US2025367217A1Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3878US2025367216A1Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3977US12337003B2Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2022·Granted Jun 24, 2025·0 cites·18 claims
- 4077US11311557B2Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Apr 26, 2022·1 cites·16 claims
- 4177US2021228599A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4275US12291549B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2021·Granted May 6, 2025·0 cites·2 claims
- 4375US2022133745A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4474US10751349B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·0 cites·22 claims
- 4574US10155787B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·1 cites·15 claims
- 4673US2021395293A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4772US2021269473A1Tgr5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4870US11807659B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·0 cites·15 claims
- 4970US11319337B23-desoxy derivative and pharmaceutical compositions thereofINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted May 3, 2022·0 cites·9 claims
- 5070US10987362B2Treatment of fibrosis using FXR ligandsINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Apr 27, 2021·0 cites·5 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →